Subscribe to an RSS Feed Reports:
Alnylam Pharmaceuticals, Inc. (ALNY):
|
Don't see the Scenario report you want?
- Competitors by Product for Alnylam Pharmaceuticals, Inc. (ALNY) Exact product by product comparables to each of a company's competitors which trade on a major US exchange. Revere - Sep 04, 2010 - HTML - $75.00 - Add to Cart »
- Drug/Medical Device for Alnylam Pharmaceuticals, Inc. (ALNY) The most complete and accurate coverage of a company's FDA approved products and pipeline candidates. Revere - Sep 04, 2010 - PDF - $70.00 - Add to Cart »
- Merger and Acquisition Scenario for APP Pharmaceuticals, Inc. (APPX) and Alnylam Pharmaceuticals, Inc. (ALNY) See what a hypothetical merger or acquisition between two firms would look like, with a particular focus on overlapping and complementary product lines and key business relationships. Revere - Sep 13, 2008 - HTML - $250.00 - Add to Cart »
- Merger and Acquisition Scenario for Abbott Laboratories (ABT) and Alnylam Pharmaceuticals, Inc. (ALNY) See what a hypothetical merger or acquisition between two firms would look like, with a particular focus on overlapping and complementary product lines and key business relationships. Revere - Jun 13, 2009 - HTML - $250.00 - Add to Cart »
- Merger and Acquisition Scenario for Abraxis Bioscience, Inc. (ABII) and Alnylam Pharmaceuticals, Inc. (ALNY) See what a hypothetical merger or acquisition between two firms would look like, with a particular focus on overlapping and complementary product lines and key business relationships. Revere - Jun 13, 2009 - HTML - $250.00 - Add to Cart »
- Merger and Acquisition Scenario for Acorda Therapeutics Inc. (ACOR) and Alnylam Pharmaceuticals, Inc. (ALNY) See what a hypothetical merger or acquisition between two firms would look like, with a particular focus on overlapping and complementary product lines and key business relationships. Revere - Jun 13, 2009 - HTML - $250.00 - Add to Cart »
- Merger and Acquisition Scenario for Adams Respiratory Therapeutics, Inc. (ARXT) and Alnylam Pharmaceuticals, Inc. (ALNY) See what a hypothetical merger or acquisition between two firms would look like, with a particular focus on overlapping and complementary product lines and key business relationships. Revere - Jan 26, 2008 - HTML - $250.00 - Add to Cart »
- Merger and Acquisition Scenario for Alexion Pharmaceuticals, Inc. (ALXN) and Alnylam Pharmaceuticals, Inc. (ALNY) See what a hypothetical merger or acquisition between two firms would look like, with a particular focus on overlapping and complementary product lines and key business relationships. Revere - Jun 13, 2009 - HTML - $250.00 - Add to Cart »
- Merger and Acquisition Scenario for Allergan, Inc. (AGN) and Alnylam Pharmaceuticals, Inc. (ALNY) See what a hypothetical merger or acquisition between two firms would look like, with a particular focus on overlapping and complementary product lines and key business relationships. Revere - Jun 13, 2009 - HTML - $250.00 - Add to Cart »
- Merger and Acquisition Scenario for Alnylam Pharmaceuticals, Inc. (ALNY) and Acorda Therapeutics Inc. (ACOR) See what a hypothetical merger or acquisition between two firms would look like, with a particular focus on overlapping and complementary product lines and key business relationships. Revere - Feb 07, 2009 - HTML - $250.00 - Add to Cart »
- Merger and Acquisition Scenario for Alnylam Pharmaceuticals, Inc. (ALNY) and Alpharma Inc. (ALO) See what a hypothetical merger or acquisition between two firms would look like, with a particular focus on overlapping and complementary product lines and key business relationships. Revere - Aug 16, 2008 - HTML - $250.00 - Add to Cart »
- Merger and Acquisition Scenario for Alnylam Pharmaceuticals, Inc. (ALNY) and Amylin Pharmaceuticals, Inc. (AMLN) See what a hypothetical merger or acquisition between two firms would look like, with a particular focus on overlapping and complementary product lines and key business relationships. Revere - Nov 15, 2008 - HTML - $250.00 - Add to Cart »
- Merger and Acquisition Scenario for Alnylam Pharmaceuticals, Inc. (ALNY) and Arena Pharmaceuticals, Inc. (ARNA) See what a hypothetical merger or acquisition between two firms would look like, with a particular focus on overlapping and complementary product lines and key business relationships. Revere - Sep 06, 2008 - HTML - $250.00 - Add to Cart »
- Merger and Acquisition Scenario for Alnylam Pharmaceuticals, Inc. (ALNY) and Auxilium Pharmaceuticals, Inc. (AUXL) See what a hypothetical merger or acquisition between two firms would look like, with a particular focus on overlapping and complementary product lines and key business relationships. Revere - Dec 13, 2008 - HTML - $250.00 - Add to Cart »
- Merger and Acquisition Scenario for Alnylam Pharmaceuticals, Inc. (ALNY) and Axcan Pharma Inc. (USA) (AXCA) See what a hypothetical merger or acquisition between two firms would look like, with a particular focus on overlapping and complementary product lines and key business relationships. Revere - Feb 16, 2008 - HTML - $250.00 - Add to Cart »
- Merger and Acquisition Scenario for Alnylam Pharmaceuticals, Inc. (ALNY) and Caraco Pharmaceutical Laboratories Ltd. (CPD) See what a hypothetical merger or acquisition between two firms would look like, with a particular focus on overlapping and complementary product lines and key business relationships. Revere - Sep 06, 2008 - HTML - $250.00 - Add to Cart »
- Merger and Acquisition Scenario for Alnylam Pharmaceuticals, Inc. (ALNY) and Chattem Inc. (CHTT) See what a hypothetical merger or acquisition between two firms would look like, with a particular focus on overlapping and complementary product lines and key business relationships. Revere - Aug 16, 2008 - HTML - $250.00 - Add to Cart »
- Merger and Acquisition Scenario for Alnylam Pharmaceuticals, Inc. (ALNY) and Crucell N.V. (ADR) (CRXL) See what a hypothetical merger or acquisition between two firms would look like, with a particular focus on overlapping and complementary product lines and key business relationships. Revere - Dec 20, 2008 - HTML - $250.00 - Add to Cart »
- Merger and Acquisition Scenario for Alnylam Pharmaceuticals, Inc. (ALNY) and Cubist Pharmaceuticals, Inc. (CBST) See what a hypothetical merger or acquisition between two firms would look like, with a particular focus on overlapping and complementary product lines and key business relationships. Revere - Aug 16, 2008 - HTML - $250.00 - Add to Cart »
- Merger and Acquisition Scenario for Alnylam Pharmaceuticals, Inc. (ALNY) and Emergent BioSolutions Inc. (EBS) See what a hypothetical merger or acquisition between two firms would look like, with a particular focus on overlapping and complementary product lines and key business relationships. Revere - Mar 07, 2009 - HTML - $250.00 - Add to Cart »